Common Contracts

GRANT AGREEMENT

Agreement • September 21st, 2023

• Contract Type
  Agreement
• Filed
  September 21st, 2023

This Agreement (“Agreement”), effective as of 1ST OCTOBER 2023, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and Sjældne Diagnoser (“Organization”) (collectively, the “Parties”).

GRANT AGREEMENT

Agreement • December 5th, 2022

• Contract Type
  Agreement
• Filed
  December 5th, 2022

This Agreement (“Agreement”), effective as of 05 December 2022, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and Patientforeningen for Lymfekræft, Leukæmi og MDS (“Organization”) (collectively, the “Parties”).

GRANT AGREEMENT

Agreement • February 28th, 2022

• Contract Type
  Agreement
• Filed
  February 28th, 2022

This Agreement (“Agreement”), effective as of 28th February 2022, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and LyLe Patientforeningen for Lymfekræft, Leukæmi og MDS, Banetoften 26, 4700 Næstved (“Organization”) (collectively, the “Parties”).